Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Plos One|December 22, 2022
Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwideRute Marcelino, Ifeanyi Jude Ezeonwumelu, André Janeiro, et al.Microbiology Spectrum|November 29, 2022
Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected IndividualsFrancisco Martin, José Maria Marcelino, Claudia Palladino, et al.Journal of Clinical Microbiology|May 19, 2017
Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected PatientsPedro Borrego, Maria Fátima Gonçalves, Perpétua Gomes, et al.AIDS (London, England)|June 15, 2012
Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremiaRita Tendeiro, Sofia Fernandes, Russell B Foxall, et al.The Journal of Organic Chemistry|July 10, 2025
Synthesis of Chiral Spirocyclopropanepenicillanates via [2 + 1] Annulation of 6-Alkylidenepenicillanates and Sulfur YlidesJoão V R Gonçalves, Ricardo M Carvalho, Jéssica Macedo, et al.Retrovirology|October 26, 2013
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody responseCheila Rocha, Rita Calado, Pedro Borrego, et al.Vaccines|April 11, 2020
A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing AntibodiesRita Calado, Joana Duarte, Pedro Borrego, et al.The Journal of Infectious Diseases|January 23, 2020
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2Philip L Tzou, Diane Descamps, Soo-Yon Rhee, et al.Plos One|May 3, 2014
Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012Claudia Palladino, Verónica Briz, José María Bellón, et al.Plos One|May 3, 2018
Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in womenInês Bártolo, Ana Rita Diniz, Pedro Borrego, et al.Pageof 9